Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Stem cells in breast cancer

Share :

EBCC 7

17 Nov 2011
Published: 22 Apr 2010
Views: 11358
Rating:
Save
Dr Robert Clarke - Paterson Institute for Cancer Research, University of Manchester, UK
Dr Clark discusses how cancer stem cells can be targeted by inhibiting the Notch signalling pathway.

Related Videos

Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )
25 Mar 2024
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...
Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )
15 Jan 2024
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer ( Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya )
10 Jan 2024
Preoperative endocrine therapy in premenopausal women leads to sparing...
Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany
Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients ( Dr Oleg Gluz - Krankenhaus Bethesda, Mönchengladbach, Germany )
28 Dec 2023
Zanidatamab, palbociclib and fulvestrant show positive results in treating...
Dr Santiago Escrivá-de-Romani - Vall d’Hebron Institute of Oncology (VHIO)...
Zanidatamab, palbociclib and fulvestrant show positive results in treating HER2+/HR+ mBC ( Dr Santiago Escrivá-de-Romani - Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain )
20 Dec 2023
Toripalimab and metronomic chemotherapy show efficacy in treating in HER2...
Dr Hongnan Mo - National Cancer Center/Cancer Hospital, Beijing, China
Toripalimab and metronomic chemotherapy show efficacy in treating in HER2-negative metastatic breast cancer ( Dr Hongnan Mo - National Cancer Center/Cancer Hospital, Beijing, China )
20 Dec 2023
ESMO 2023: Highlights and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Nov 2023
Updates on HR-positive HER2-negative breast cancer
Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA
Updates on HR-positive HER2-negative breast cancer ( Dr Mariana Chavez - MD Anderson Cancer Center, Houston, USA )
8 Jul 2023
Updates on triple-negative breast cancer and immunotherapy
Dr Avan Armaghani - Moffitt Cancer Center, Tampa, USA
Updates on triple-negative breast cancer and immunotherapy ( Dr Avan Armaghani - Moffitt Cancer Center, Tampa, USA )
7 Jul 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation